All Posts

Backing Atomic Tessellator: Sovereign Capability at the Atomic Level

0 Mins Read

Why We Backed a Biosecurity Platform Before Anyone Was Talking About It

Share

When one nation controls 70% of the world's critical minerals, that isn't a supply chain risk — it's a strategic vulnerability.

Sovereign Capability at the Atomic Level

When one nation controls 70% of the world's critical minerals — the materials underpinning defence, aerospace and critical industry — that isn't a supply chain risk. It's a strategic vulnerability.

That's why we're proud to double down on Atomic Tessellator, which today announces its $11.3 million seed round, led by Crane Venture Partners with new institutional partners including our good friends at IQT.

From the moment we met founder and CEO Alain Richardt, it was clear this was a different kind of deep tech company: world-class science, an urgent mission, and an exceptional founder whose obsession has been a genuine joy to back.

Atomic Tessellator's simulation-first platform compresses what once took three to four years in a lab down to weeks, at under 1% of the cost — arriving at synthesis with high-confidence candidates, not untested hypotheses.

Today the company also unveils Vireon: the world's first rare earth-free magnet to outperform existing rare earth alternatives on key performance metrics. Behind it sits a pipeline of 20 novel material candidates, many already in lab synthesis. This is what sovereign capability looks like at the materials level.

"Material chemistry is often at the foundation of the technology we back. Atomic Tessellator is solving sovereign supply chain risk at the atomic level — designing new materials with predictable procurement." — Dan Bennett, Founding Partner, Salus Ventures

"Vireon isn't a theoretical result. It's a lab-verified, better-performing material ready for commercialisation. A world-class team doing world-class work." — Archie Judd, Salus Ventures

Congratulations to Alain and the whole Atomic Tessellator team. The decisions being made right now about where next-generation materials infrastructure is built will define strategic advantage for decades.

Join our mission

We provide early capital for
the future

We provide early capital for the future

The Salus VC group of companies (The Salus VC Group) includes various entities who are corporate authorised representatives (CAR) of Boutique Capital Pty Ltd ACN 621 697 621 (Boutique Capital) AFSL 508011. These entities are: Salus VC Pty Ltd ACN 660 225 249 (AR 1299225); Salus VC Fund, LP ILP2200056 (AR 1299226); Salus VC Management Partnership, LP ILP2200055 (AR 1299227); Salus VC StapleCo Pty Ltd ACN 660 236 206 (AR 1299228); SVC Nominee Pty Ltd (AR 1308663); Salus Ventures Fund II Management Partnership, LP ILP2600667 (AR 1321407); Salus Ventures Fund II, LP ILP2600668 (AR 1321408); Salus Ventures Fund II StapleCo Pty Ltd (AR 1321409).

Any information or advice is general advice only and has been prepared by The Salus VC Group for individuals identified as wholesale investors for the purposes of providing a financial product or financial service, under Section 761G or Section 761GA of the Corporations Act 2001 (Cth). Any information or advice given does not take into account your particular objectives, financial situation or needs and before acting on the advice, you should consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If any advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

Terms & Privacy

The Salus VC group of companies (The Salus VC Group) includes various entities who are corporate authorised representatives (CAR) of Boutique Capital Pty Ltd ACN 621 697 621 (Boutique Capital) AFSL 508011. These entities are: Salus VC Pty Ltd ACN 660 225 249 (AR 1299225); Salus VC Fund, LP ILP2200056 (AR1299226); Salus VC Management Partnership, LP ILP2200055 (AR 1299227); Salus VC StapleCo Pty Ltd ACN 660 236 206 (AR1299228); SVC Nominee Pty Ltd (AR 1308663); Salus Ventures Fund II Management Partnership, LP ILP2600667 (AR 1321407); Salus Ventures Fund II, LP ILP2600668 (AR 1321408); Salus Ventures Fund II StapleCo Pty Ltd (AR 1321409). Any information or advice is general advice only and has been prepared by The Salus VC Group for individuals identified as wholesale investors for the purposes of providing a financial product or financial service, under Section 761G or Section 761GA of the Corporations Act 2001 (Cth). Any information or advice given does not take into account your particular objectives, financial situation or needs and before acting on the advice, you should consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If any advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

Terms & Privacy

The Salus VC group of companies (The Salus VC Group) includes various entities who are corporate authorised representatives (CAR) of Boutique Capital Pty Ltd ACN 621 697 621 (Boutique Capital) AFSL 508011. These entities are: Salus VC Pty Ltd ACN 660 225 249 (AR 1299225); Salus VC Fund, LP ILP2200056 (AR 1299226); Salus VC Management Partnership, LP ILP2200055 (AR 1299227); Salus VC StapleCo Pty Ltd ACN 660 236 206 (AR 1299228); SVC Nominee Pty Ltd (AR 1308663); Salus Ventures Fund II Management Partnership, LP ILP2600667 (AR 1321407); Salus Ventures Fund II, LP ILP2600668 (AR 1321408); Salus Ventures Fund II StapleCo Pty Ltd (AR 1321409).

Any information or advice is general advice only and has been prepared by The Salus VC Group for individuals identified as wholesale investors for the purposes of providing a financial product or financial service, under Section 761G or Section 761GA of the Corporations Act 2001 (Cth). Any information or advice given does not take into account your particular objectives, financial situation or needs and before acting on the advice, you should consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If any advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

Terms & Privacy

The Salus VC group of companies (The Salus VC Group) includes various entities who are corporate authorised representatives (CAR) of Boutique Capital Pty Ltd ACN 621 697 621 (Boutique Capital) AFSL 508011. These entities are: Salus VC Pty Ltd ACN 660 225 249 (AR 1299225); Salus VC Fund, LP ILP2200056 (AR 1299226); Salus VC Management Partnership, LP ILP2200055 (AR 1299227); Salus VC StapleCo Pty Ltd ACN 660 236 206 (AR 1299228); SVC Nominee Pty Ltd (AR 1308663); Salus Ventures Fund II Management Partnership, LP ILP2600667 (AR 1321407); Salus Ventures Fund II, LP ILP2600668 (AR 1321408); Salus Ventures Fund II StapleCo Pty Ltd (AR 1321409).

Any information or advice is general advice only and has been prepared by The Salus VC Group for individuals identified as wholesale investors for the purposes of providing a financial product or financial service, under Section 761G or Section 761GA of the Corporations Act 2001 (Cth). Any information or advice given does not take into account your particular objectives, financial situation or needs and before acting on the advice, you should consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If any advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

Terms & Privacy